|4Dec 26, 10:02 AM ET

Gardner Donald T. III 4

4 · KEWAUNEE SCIENTIFIC CORP /DE/ · Filed Dec 26, 2024

Insider Transaction Report

Form 4
Period: 2024-12-24
Gardner Donald T. III
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2024-12-24$56.74/sh947$53,73323,717 total
  • Sale

    Common Stock

    2024-12-24$58.22/sh583$33,94223,134 total
  • Sale

    Common Stock

    2024-12-24$59.88/sh221$13,23322,913 total
  • Sale

    Common Stock

    2024-12-24$61.42/sh255$15,66222,658 total
  • Sale

    Common Stock

    2024-12-24$62.00/sh43$2,66622,615 total
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.50 to $57.40 inclusive. The reporting person undertakes to provide Kewaunee Scientific Corporation ("Kewaunee"), any security holder of Kewaunee, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.95 to $58.71 inclusive. The reporting person undertakes to provide Kewaunee Scientific Corporation ("Kewaunee"), any security holder of Kewaunee, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.68 to $60.51 inclusive. The reporting person undertakes to provide Kewaunee Scientific Corporation ("Kewaunee"), any security holder of Kewaunee, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.73 to $61.65 inclusive. The reporting person undertakes to provide Kewaunee Scientific Corporation ("Kewaunee"), any security holder of Kewaunee, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.01 inclusive. The reporting person undertakes to provide Kewaunee Scientific Corporation ("Kewaunee"), any security holder of Kewaunee, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Documents

1 file
  • 4
    wk-form4_1735225341.xmlPrimary

    FORM 4